ConcertAI, a pacesetter in oncology generative and agentic AI SaaS and multi-modal knowledge (MMD) options for healthcare and life sciences, at present introduced the appointment of Michael Myshrall as chief monetary officer (CFO). Myshrall brings over twenty years of monetary management expertise in SaaS, synthetic intelligence (AI) and expertise sectors, positioning him to assist speed…
Actual-World Proof and Longitudinal Affected person Information-Pushed Algorithm Delivers Actionable, AI-Powered Insights on the Level of Care Atropos Well being, a frontrunner in translating real-world scientific information into customized real-world proof (RWE) and insights, right now introduced a collaboration with Novartis. Via this strategic collaboration, Atropos Well being will construct, prepare and consider a number…
AQ provides AI-powered instruments to assist determine fraudulent medical advertisements and well being misinformation, with options designed for seniors. Supported by 200,000+ physicians and nationwide schooling periods, the initiative is devoted to fostering a extra reliable, inclusive healthcare atmosphere in China. Ant Group has rolled out a serious initiative via its AI healthcare app AQ to fight well…
Tevogen.AI to explore external market opportunities as a potential revenue source. Beta version to incorporate oncology targets, enhancing the accuracy and diversity of the PredicTcell model and potentially accelerating cancer immunotherapy development. Tevogen.AI to develop enhanced analytics and visualization tools, for the PredicTcell model to support its internal R&D teams. Tevogen (“Tevogen Bio Holdings Inc.” or…
VivaQuant, Inc. d.b.a. Rhythm Express, a leader in remote cardiac monitoring and digital health solutions, has been recognized as one of the fastest-growing private companies in the United States by Inc. Magazine for the third consecutive year, ranking #331. VivaQuant’s continued recognition reflects the company’s momentum in reshaping the future of cardiac care through intelligent…
More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and setting a new global benchmark A potential game changer that addresses both the pain of injections and the low efficiency of oral formulations In the obesity treatment market, delivery technology is expected to be…
Smartee Denti-Technology announces the publication of a case report on the application of the S8-SGTB clear aligner therapy for treating adult Class II malocclusion in the Journal of Aligner Orthodontics (JAO). The report, titled “Treatment of Class II malocclusion with sagittal guidance twin block clear aligners (S8-SGTB): A report of three cases,” presents the process and outcomes of three…
HopeAI, an emerging leader in applying artificial intelligence (AI) to accelerate new drug development, has officially joined the prestigious Mayo Clinic Platform Accelerate program. This partnership grants HopeAI access to Mayo Clinic’s world-class real-world data (RWD) platform, enabling faster, smarter, and more confident clinical trial design. Bringing a new drug to market is one of the most…
Study Confirms Regulatory-Grade Performance and AI-Driven Clinical Utility to Advance Precision Oncology and Patient Stratification for Drug Development BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced the publication of a pivotal study, “Clinical and analytical validation of a combined RNA and DNA exome assay across a large tumor cohort,” in Communications…
Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its platform, Techcyte Fusion (research use only (RUO) in the US, CE-IVDD-marked in Europe), now includes Modella AI, a biomedical artificial intelligence company at the forefront of computational pathology, as a partner in the Techcyte Fusion Partner Program. This collaboration brings…